UVA Health research sheds light on the best second-line treatment for status epilepticus, a neurological emergency that can cause brain damage or even death.
Author: Luis Soler Rivera (Page 4)
An international UVA Health research partnership with the ISGC has uncovered previously unknown genetic mechanisms related to stroke risk. These studies underline UVA Health's commitment to prevent stroke and improve treatment.
Over the past 2 decades, a UVA researcher has found new sites in the genome related to type 1 diabetes that could revolutionize screening and therapy.
UVA Health’s groundbreaking research finds strong evidence fluoxetine could help slow or prevent the leading cause of blindness in older adults, age-related dry macular degeneration.
Combining robust expertise with the latest robotics improves outcomes and reduces knee replacement revisions.
UVA Health continues to improve the lives of cancer patients with two new focused ultrasound clinical trials for bolstering treatment and pain palliation.